Prof Eliza Hawkes
Honorary Professorial Fellow
Department of Medicine
329 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Prognostic survival models for diffuse large B-cell lymphoma using statistical and machine learning approaches.
DOI: 10.1038/s41698-026-01604-w2026
Journal article
Low lymphoma macrophage infiltration predicts poor outcomes in R-CHOP- but not Pola-R-CHP-treated patients with DLBCL
DOI: 10.1016/j.bneo.2026.1002642026
Journal article
Marked variation in eligibility criteria across registrational trials for relapsed diffuse large B-cell lymphoma limits applicability to clinical practice
DOI: 10.1111/bjh.705502026
Journal article
Diagnosis-to-treatment interval is associated with outcomes in follicular lymphoma treated with immunochemotherapy
DOI: 10.1182/blood.20260330902026
Journal article
Golcadomide (GOLCA), a potential, first-in-class, oral CELMoD, plus rituximab (R) versus investigator’s choice (IC) in patients (pts) with relapsed/refractory follicular lymphoma (R/R FL) who have received ≥ 1 line of systemic therapy: GOLSEEK-4, a phase (Ph) 3, randomized study.
DOI: 10.1200/jco.2026.44.16_suppl.tps71022026
Journal article
Checkpoint inhibitors, obinutuzumab plus PET-adapted ultra-low dose nodal radiotherapy yield high efficacy in treatment-naïve follicular lymphoma: Results from the phase II ‘FLUORO’ study
DOI: 10.1111/bjh.704682026
Journal article
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.
DOI: 10.1182/bloodadvances.2026020012
RECENT SCHOLARLY WORKS
2026
Journal article
Toxicity outcomes in phase 1 lymphoma trials abstracts are under-reported, with high use of minimizing language
DOI: 10.1002/hem3.703512026
Journal article
Body Mass Index and Clinical Associations in Australasian Lymphoma Patients: A Lymphoma and Related Diseases Registry Study
DOI: 10.1002/jha2.702122026
Journal article
The gut microbiome in B cell lymphoma
DOI: 10.1016/j.blre.2025.101357